POCT stands for point-of-care testing, a type of medical diagnostic testing performed at or near the site where you receive care rather than in a centralized laboratory. Instead of drawing your blood and sending it to a lab across the hospital or across town, a healthcare provider runs the test right there, often with a handheld device or small analyzer, and gets results in minutes. The most familiar example for many people is a blood glucose meter, but POCT now spans dozens of tests used in emergency rooms, primary care clinics, pharmacies, and even at home.
How POCT Differs From Traditional Lab Testing
The defining advantage of point-of-care testing is speed. In a randomized controlled trial comparing POCT to conventional lab processing in an emergency department, the lab turnaround time for point-of-care devices was about 5 minutes, compared to roughly 88 minutes for samples sent to a central laboratory. That difference cascades through your entire visit: the median time from arrival to a treatment decision dropped from about 205 minutes with standard lab work to 107 minutes with POCT, and overall time spent in the emergency department fell from nearly 6.5 hours to 4 hours.
Speed matters most when treatment decisions hinge on a single result. If a doctor needs to know your blood sugar, your blood clotting time, or whether you’re positive for the flu before choosing a next step, waiting 90 minutes for a central lab creates a bottleneck. POCT removes it.
What Makes a Test “Point-of-Care”
Not every portable test qualifies. The World Health Organization developed the ASSURED framework to describe what a good point-of-care test should be: affordable, sensitive, specific, user-friendly, rapid, robust, equipment-free, and deliverable to the people who need it. A more recent update, called REASSURED, adds two requirements: real-time connectivity (so results can flow into health information systems) and ease of specimen collection, meaning the test should work with minimally invasive samples like a fingerstick or saliva swab rather than a full blood draw.
In practice, the test also needs to produce results consistent with what a full-size laboratory instrument would deliver, and the reagents and consumables have to stay stable during storage. A test that’s fast but inaccurate, or one that requires refrigeration in a setting without reliable power, doesn’t serve the purpose.
The Technology Inside POCT Devices
Most point-of-care devices rely on one of two core detection methods: electrochemical sensing or optical measurement.
Electrochemical sensors are what power blood glucose meters. A test strip contains an enzyme that reacts with the target substance in your blood, generating a tiny electrical current. The device reads that current and converts it to a number. The same principle drives portable blood-clotting monitors, which measure how quickly your blood forms a clot and display the result in seconds.
Optical devices, by contrast, shine a light through the sample and measure what comes back. A portable hemoglobin analyzer, for instance, uses a tiny sample chamber pre-loaded with dried reagents. When blood enters the chamber, a chemical reaction changes its color, and the device reads light absorption to calculate your hemoglobin level. Other analyzers use LEDs to measure both reflected and transmitted light for tests like cholesterol or inflammation markers.
Lateral flow assays are the simplest format. These are the paper-strip tests behind home pregnancy tests, rapid COVID antigen tests, and rapid strep tests. A liquid sample wicks along a strip, and if the target molecule is present, it binds to labeled antibodies and produces a visible line. No electronics required.
Common POCT Tests You Might Encounter
The most widely requested point-of-care test in primary care settings is hemoglobin A1c (HbA1c), which reflects average blood sugar over the past two to three months. In a survey of family medicine clinics, HbA1c topped the list at nearly 17% of all POCT requests, followed by electrolyte panels (10%), HIV and sexually transmitted infection screening (9.4%), kidney function markers (6.1%), and urine drug testing (5.4%).
Beyond primary care, the landscape is broader. Emergency departments commonly use point-of-care blood gas analyzers, cardiac biomarker tests, and rapid flu and strep tests. Pharmacies and community health centers offer rapid HIV screening. And at home, millions of people use glucose meters, home pregnancy tests, and COVID antigen kits, all of which are forms of POCT.
POCT in Diabetes Management
Diabetes care is where point-of-care testing has shown some of its clearest benefits. When HbA1c results are available to a doctor during the appointment rather than days later from a lab, treatment decisions change in real time. In a randomized trial of 201 insulin-treated patients, those whose HbA1c results were available at the start of their visit saw their levels drop by 0.57 percentage points at six months, and that improvement held at twelve months. Patients in the control group, who received lab results after the visit, showed no significant change.
The mechanism is straightforward. When doctors see an elevated HbA1c while the patient is still in the room, they’re more likely to adjust treatment on the spot. One study found that treatment changes for patients with high readings jumped from 28.6% to 53.8% after a clinic adopted point-of-care HbA1c testing. Guideline-compliant testing frequency also improved dramatically, rising from about 66% to 95% within six months of implementation. A large retrospective study found that these improvements in blood sugar control were still detectable 3.5 years later.
POCT in Emergency and Infectious Disease Settings
In emergency medicine, rapid cardiac testing is one of the highest-stakes applications. Point-of-care troponin tests, used to help diagnose heart attacks, have high specificity (around 90%) but lower sensitivity (around 47%) when measured across large studies. That means a positive result is quite reliable, but a negative result doesn’t rule out a heart attack on its own. When testing is performed more than three hours after the onset of chest pain, sensitivity improves to about 66% and specificity rises to 95%. Doctors typically use these rapid results as one piece of a larger diagnostic picture rather than as a standalone verdict.
For infectious diseases, POCT has transformed screening in resource-limited settings. Rapid HIV tests can detect antibodies in a fingerstick blood sample or even an oral swab, providing results in 20 minutes or less. Fourth-generation combination tests have narrowed the diagnostic window to within two weeks of transmission by detecting both antibodies and a viral protein called p24 that appears very early in infection. Rapid tests for influenza, strep throat, RSV, and malaria follow similar principles, giving clinicians enough information to start treatment during the same visit.
Regulatory Requirements in the U.S.
In the United States, point-of-care tests are regulated by the FDA and categorized under a system called CLIA (Clinical Laboratory Improvement Amendments). Tests fall into three complexity tiers: waived, moderate complexity, and high complexity. The simplest tests receive a “CLIA waiver,” which allows them to be performed in settings like doctors’ offices, pharmacies, and clinics without the full laboratory infrastructure required for more complex testing.
To earn a waiver, a manufacturer must demonstrate that the test is simple enough that the likelihood of user error is negligible, or that an incorrect result poses no unreasonable risk of harm. The FDA reviews the device design, potential sources of error, built-in safeguards, and studies showing the test performs reliably even under stressed conditions like temperature extremes or inexperienced users. Tests approved for home use are automatically categorized as waived.
Challenges With POCT Adoption
Despite the speed advantage, integrating point-of-care results into the broader healthcare system remains a significant challenge. One of the biggest hurdles is getting test data into electronic health records automatically. Many POCT devices still require manual data entry, which introduces errors and creates extra work for staff. There are no universal standards across all devices and health record platforms, so a glucose reading from one manufacturer’s device may not seamlessly flow into every clinic’s system.
Data governance raises additional questions. When a patient generates health data at home using a POCT device, it’s not always clear who is responsible for reviewing that data, how it should be stored, or when it warrants clinical action. Privacy, security, and the legal status of patient-generated data are still being worked out at the national level. Access is also uneven: patients in rural areas may lack broadband internet needed for connected devices, and older patients or those with limited tech experience may struggle with device setup. The cost of devices and consumables can be a barrier for uninsured patients, even when the test itself is simple.
Accuracy is another consideration. While POCT devices have improved enormously, they generally carry slightly wider margins of error than full-size laboratory instruments. For screening purposes or routine monitoring, this tradeoff is usually acceptable. For high-stakes diagnostic decisions, clinicians often confirm point-of-care results with conventional lab testing.
Where POCT Is Heading
The point-of-care testing market is projected to grow at roughly 8.6% per year through 2033, driven by three converging trends. First, devices are increasingly designed to connect directly with health apps and cloud-based platforms, making it easier to share results with care teams in real time. Second, wearable technology is blurring the line between monitoring and testing. Continuous glucose monitors are already mainstream, and similar wearable sensors for other biomarkers are in development. Third, artificial intelligence is being built into POCT platforms to improve diagnostic accuracy, flag abnormal patterns, and reduce the chance of human error during interpretation.